# The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.

> **NCT00233805** · PHASE2 · COMPLETED · sponsor: **Cordis US Corp.** · enrollment: 220 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Sirolimus coated Bx Velocity™
- **DEVICE:** Bare metal Bx Velocity™

## Key facts

- **NCT ID:** NCT00233805
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2008-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00233805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00233805, "The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00233805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*